The poor prognosis of human malignant gliomas is due to their invasion
and recurrence, the molecular mechanisms of which remain poorly chara
cterized. We have accumulated substantial evidence implicating the cys
teine protease cathepsin B in human glioma malignancy. Increases in ca
thepsin B expression were observed throughout progression. In primary
brain tumor tissue, transcript abundance (Northern blot analysis) incr
eased in low-grade astrocytoma to high-grade glioblastoma from 3- to 6
-fold, respectively, above normal brain levels. This increase correlat
ed with increases in protein abundance (from + to +++) as measured by
immunohistochemistry. Furthermore, in glioblastoma cell fines increase
s in transcript abundance (ranging from 3- to 12-fold) were accompanie
d by increases in enzyme activity (44-133 nmol/min x mg protein). Alte
red subcellular localization was observed both immunohistochemically a
nd by indirect immunofluorescence confocal microscopy and was found to
correlate with increased grade. In addition, this increase in catheps
in B expression and altered subcellular localization correlated with h
istomorphological invasion and clinical evidence of invasion as detect
ed by magnetic resonance imaging. These data support the hypothesis th
at cathepsin B plays a role in human glioma progression and invasion.